• Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016
Monday Morning
Skip to content
  • Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016

Tag Archives: Entera Bio Inc.

Biotech IPOs smash record in H1, soaking up huge raises from the cash still parked on the sidelines. Will supply of buyers run out, like always?

Steve Walker    July 6, 2018 July 6, 2018    No Comments on Biotech IPOs smash record in H1, soaking up huge raises from the cash still parked on the sidelines. Will supply of buyers run out, like always?

The News: Last week the Nasdaq Biotech Index swooned 4% on Wednesday (July 27, 2018), only to rebound and halve that downdraft by Friday’s close (July 29, 2018). But despite… Read more »

Disease, Investment, Pharmaceuticals    Aquestive Therapeutics Inc., Bionano Genomics Inc., Entera Bio Inc., Forty Seven Inc., IPO, Liquidia Technologies Inc., Neon Therapeutics Inc., Neuronetics Inc., Translate Bio Inc., Tricida Inc.

Search The Site

Follow @MonMorningNews

Twitter

Tweets by MonMorningNews
Follow me on Blogarama

Facebook

Search The Site

More MondayMorning

  • Recent Posts
  • Most Commented
  • Most Viewed
  • Insys trial opens with tale of sales rep giving lap dance to doctor for fentanyl prescriptions. News organizations seize upon...
  • Three healthcare stocks shine while two fizzle to cap the first month of 2019’s investor lottery. Who’s a rational bet...
  • IPOs are back in business; well, unless and until there’s another government shutdown.
  • And now for something completely different in biotech: Lab-grown, “clean” meat. If Bill Gates and Warren Buffett like the idea...well?...
    • Elizabeth Holmes and Mark Zuckerberg: The rise and fall of the black turtleneck, hoodie and jeans. Op Ed
    • Unknown Kentucky biotech Bexion tests new glioma med on first patients. Yes, it’s the same cancer Sen. McCain is fighting,...
    • Biotech IPOs rock in 2018. More are storming into the queue.
    • Apitope moves Graves’ disease candidate toward Phase 2; a primer on autoimmune disease “for people in a hurry.”
    Copyright 2018
    Ribosome by GalussoThemes.com
    Powered by WordPress